Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
9.29
-0.69 (-6.91%)
Jun 3, 2026, 11:17 AM EDT - Market open
Fennec Pharmaceuticals Employees
Fennec Pharmaceuticals had 35 employees as of December 31, 2025. The number of employees increased by 3 or 9.38% compared to the previous year.
Employees
35
Change (1Y)
3
Growth (1Y)
9.38%
Revenue / Employee
$1,457,114
Profits / Employee
-$239,286
Market Cap
322.71M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 35 | 3 | 9.38% |
| Dec 31, 2024 | 32 | 3 | 10.34% |
| Dec 31, 2023 | 29 | -7 | -19.44% |
| Dec 31, 2022 | 36 | 26 | 260.00% |
| Dec 31, 2021 | 10 | 1 | 11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| REGENXBIO | 371 |
| Puma Biotechnology | 179 |
| Lyell Immunopharma | 161 |
| Nautilus Biotechnology | 127 |
| Invivyd | 122 |
| Enanta Pharmaceuticals | 120 |
| Prelude Therapeutics | 79 |
| Larimar Therapeutics | 71 |
FENC News
- 12 days ago - Fennec price target raised to $16 from $13 at H.C. Wainwright - TheFly
- 12 days ago - Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting - GlobeNewsWire
- 15 days ago - Fennec Pharmaceuticals Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 15 days ago - Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 16 days ago - Fennec Pharmaceuticals Slides: Corporate presentation - Filings
- 20 days ago - Fennec Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 20 days ago - Fennec Pharmaceuticals Earnings release: Q1 2026 - Filings
- 20 days ago - Fennec Pharmaceuticals Quarterly report: Q1 2026 - Filings